VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 10, 2013) - TerraBioGen Technologies Inc., a developer of proprietary, organic-based, high-value agriculturally and horticulturally bioactive products, announces that it has moved to new premises.

Since inception almost 20 years ago, the Company has operated out of a facility in North Vancouver. That facility was primarily used to process food waste for conversion into a liquid or granular fertilizer product. The Company sold licenses for this technology and continued its research to refine and define the acitive ingredients found in its end products. In mid-2011, TerraBioGen changed its focus from waste conversion to research and development based on the isolation of the bioactive materials that impacted the end product performance.

The new facility, located at 8536 Baxter Place in Burnaby, British Columbia, was designed with its new focus in mind and will be used both for research and development, and marketing and administrative activities. TerraBioGen is actively working on the further development, formulation and patenting of additional agriculturally bioactive compounds. The Company's growing trials over the next 18 months will focus on the formulation and delivery of these materials to a wide range of horticultural and agricultural applications.

About TerraBioGen

TerraBioGen Technologies Inc. is committed to research and development to continue to improve the efficiency of its technology, its methodology and the quality of its horticultural and agricultural products. It is further committed to the global commercialization of its technology and ensuring the market acceptance of its products.

This news release contains certain statements that may be deemed "forward-looking" statements. Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although TerraBioGen believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of TerraBioGen's management on the date the statements are made. Except as required by law, TerraBioGen undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS REGISTERED OR EXEMPT THEREFROM.